Where Avadel Pharmaceuticals Stands With Analysts
Portfolio Pulse from Benzinga Insights
Avadel Pharmaceuticals (NASDAQ:AVDL) has received positive analyst ratings in the last quarter, with 6 bullish and 2 somewhat bullish ratings. The average price target for the stock is $19.62, a 12.11% increase from the previous target of $17.50, implying an upside from the current price of $11.1.
September 25, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avadel Pharmaceuticals has received positive analyst ratings, which could potentially drive the stock price up in the short term.
Analyst ratings are a significant factor that investors consider when making investment decisions. The positive ratings for Avadel Pharmaceuticals indicate a bullish sentiment towards the stock, which could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100